A 78-Year Old Urothelial Cancer Patient with Faster Recovery from COVID-19: Potential Benefit from Adjuvant Active Immunotherapy

SSRN Electronic Journal(2020)

引用 0|浏览3
暂无评分
摘要
A 78-year old male patient under active immunotherapy for high-grade non-muscle invasive bladder cancer presented severe COVID-19. A shorter hospitalization period was observed, leading to the hypothesis of active immunotherapy (OncoTherad) crucial role in association to antiviral and anti-inflammatory treatment in preventing the evolution of pulmonary symptoms to a poor prognosis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要